Business Context and Reporting Period
Company: SMX (Security Matters) Public Limited Company (SMX)
Reporting Period: Fiscal Year Ended December 31, 2025
Business Overview: SMX provides a track-and-trace and authentication solution using sub-molecular markers, readers, and blockchain technology to ensure supply chain integrity and support the circular economy. The company operates across multiple sectors including plastics, rubber, precious metals, and fashion. It is an Irish-domiciled foreign private issuer listed on Nasdaq (SMX) with significant operations in Israel, Australia, and Singapore.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 (US$ Thousands) | 2024 (US$ Thousands) |
|---|---|---|
| Revenue | 0 | 0 |
| Operating Loss | (146,289) | (27,865) |
| Net Loss | (174,590) | (35,401) |
| Net Loss Attributable to Shareholders | (169,178) | (31,092) |
| Cash and Cash Equivalents (End of Period) | 12,201 | 2,343 |
| Net Cash Used in Operating Activities | (17,001) | (11,314) |
| Net Cash Provided by Financing Activities | 29,745 | 13,110 |
| Total Current Liabilities | 21,732 | 20,800 |
| Convertible Notes (Current) | 8,295 | 3,651 |
| Accumulated Losses | (251,204) | (82,026) |
Note: The company has not generated revenue to date. Expenses are heavily driven by non-cash share-based compensation ($114.2 million in 2025) and finance costs related to convertible notes and fair value adjustments.
Material Changes vs. Prior Period
- Operating Loss Expansion: Operating loss increased by 425% to $146.3 million, primarily due to a $98.8 million increase in non-cash share-based payment expenses, higher general and administrative costs, and $10.9 million in impairment and amortization charges.
- Finance Costs: Net finance expenses surged to $28.3 million (expenses of $40.7M less income of $12.4M), driven by interest on borrowings and fair value revaluations of convertible notes and bridge loans.
- Liquidity Position: Cash balances increased from $2.3 million to $12.2 million, supported by $29.7 million in net financing proceeds, primarily from the issuance of convertible notes and warrants.
- Capital Structure: Significant dilution occurred through the conversion of debt to equity and the issuance of shares to settle liabilities. The company executed multiple reverse stock splits in 2025 and a final split in February 2026.
Guidance, Outlook, Risks, and Contingencies
Going Concern Warning
The financial statements contain an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern. The company has incurred recurring losses, negative cash flows from operations, and relies on external financing to meet obligations. Management plans to address this through the Standby Equity Purchase Agreement (SEPA), debt conversions, and strategic partnerships.
Liquidity and Capital Resources
- SEPA Facility: Entered into a Standby Equity Purchase Agreement (SEPA) with Target Capital 1 LLC. The commitment was increased to $250 million in February 2026. As of the filing date, approximately $17.7 million had been drawn down.
- Debt Obligations: The company has significant current liabilities ($21.7 million), including trade payables and convertible notes. Several notes (e.g., RBW December, Abri) were converted to equity or settled in early 2026.
Material Risks and Contingencies
- Legal Proceedings: Engaged in arbitration with R&I Trading regarding a terminated $5 million contract. The outcome is uncertain, and the company is defending against claims for restitution while seeking damages for breach of contract.
- Intellectual Property: Operations rely on a license from Isorad Ltd. (State of Israel). Termination of this agreement would materially harm the business. Royalties are payable on gross sales (2.2% generally, 4.2% for specific affiliates).
- Geopolitical Risks: Significant operations and R&D are located in Israel. Ongoing conflicts and military reserve duty call-ups pose risks to operations and personnel availability.
- Nasdaq Compliance: The company has received deficiency letters regarding minimum bid price requirements in the past. While compliance was regained, failure to maintain listing standards could result in delisting.
Key Facts for Investor Verification
- Revenue Status: Verify the timeline for converting Proof-of-Concept (POC) pilots into revenue-generating commercial contracts, as the company currently has $0 revenue.
- Going Concern Mitigation: Confirm the status of the $250 million SEPA facility and the company's ability to draw down funds without triggering further dilution or default on existing covenants.
- Debt Conversion Terms: Review the specific conversion prices and dilution impact of the recent convertible note conversions (RBW, Alpha, PMB) and the remaining outstanding debt obligations.
- Arbitration Outcome: Monitor the R&I Trading arbitration proceedings, as a negative outcome could result in significant cash outflows or asset seizures.
- Share-Based Compensation: Assess the sustainability of the $114 million share-based compensation expense, which significantly inflates the reported net loss but does not impact cash flow directly.